153 related articles for article (PubMed ID: 36944108)
21. Hypersensitivity Reactions to Multiple Iodinated Contrast Media.
Doña I; Bogas G; Salas M; Testera A; Moreno E; Laguna JJ; Torres MJ
Front Pharmacol; 2020; 11():575437. PubMed ID: 33071787
[TBL] [Abstract][Full Text] [Related]
22. A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol in more than 57,000 patients: part 1-intravenous administration.
van der Molen AJ; Dekkers IA; Bedioune I; Darmon-Kern E
Eur Radiol; 2022 Aug; 32(8):5532-5545. PubMed ID: 35312790
[TBL] [Abstract][Full Text] [Related]
23. Assessment of immediate and non-immediate hypersensitivity contrast reactions by skin tests and provocation tests: A review.
Bansie RD; Karim AF; van Maaren MS; Hermans MA; van Daele P; Gerth van Wijk R; Rombach SM
Int J Immunopathol Pharmacol; 2021; 35():20587384211015061. PubMed ID: 34053316
[TBL] [Abstract][Full Text] [Related]
24. Differences in the Recurrence Rate of Immediate Adverse Drug Reactions According to the Components of Alternative Contrast Media: Analysis of Repetitive Computed Tomography Cases in a Single Tertiary Hospital.
Kim SR; Son NH; Park HJ; Park KH; Park JW; Lee JH
Drug Saf; 2022 Sep; 45(9):995-1002. PubMed ID: 35908149
[TBL] [Abstract][Full Text] [Related]
25. Incidence and Risk Factors of Immediate Hypersensitivity Reactions Associated With Low-Osmolar Iodinated Contrast Media: A Longitudinal Study Based on a Real-Time Monitoring System.
Lee SY; Kang DY; Kim JY; Yoon SH; Choi YH; Lee W; Cho SH; Kang HR
J Investig Allergol Clin Immunol; 2019; 29(6):444-450. PubMed ID: 30676320
[TBL] [Abstract][Full Text] [Related]
26. Clinical features and risk factors of iodinated contrast media (ICM)-induced anaphylaxis.
Fukushima Y; Taketomi-Takahashi A; Suto T; Hirasawa H; Tsushima Y
Eur J Radiol; 2023 Jul; 164():110880. PubMed ID: 37187078
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and Prevention of Hypersensitivity Reactions to Iodinated Contrast Media.
Kang HR; Jeong J; Brockow K
Allergy Asthma Immunol Res; 2022 Jul; 14(4):348-360. PubMed ID: 35837820
[TBL] [Abstract][Full Text] [Related]
28. Skin Testing for Suspected Iodinated Contrast Media Hypersensitivity.
Schrijvers R; Breynaert C; Ahmedali Y; Bourrain JL; Demoly P; Chiriac AM
J Allergy Clin Immunol Pract; 2018; 6(4):1246-1254. PubMed ID: 29371073
[TBL] [Abstract][Full Text] [Related]
29. Delayed hypersensitivity reactions to iodinated contrast media: A diagnostic approach by skin tests.
Bianchi L; Hansel K; Biondi F; Caroppo ES; Galeotti T; Casciola G; Tramontana M; Marietti R; Napolitano M; Patruno C; Stingeni L
Contact Dermatitis; 2023 Nov; 89(5):352-358. PubMed ID: 37394777
[TBL] [Abstract][Full Text] [Related]
30. Acute Adverse Events After Iodinated Contrast Agent Administration of 359,977 Injections: A Single-Center Retrospective Study.
McDonald JS; Larson NB; Schmitz JJ; Kolbe AB; Hunt CH; Hartman RP; Hagan JB; Kallmes DF; McDonald RJ
Mayo Clin Proc; 2023 Dec; 98(12):1820-1830. PubMed ID: 38043998
[TBL] [Abstract][Full Text] [Related]
31. Iodinated Contrast Media Substitution to Prevent Recurrent Hypersensitivity Reactions: A Systematic Review and Meta-Analysis.
Umakoshi H; Nihashi T; Takada A; Hirasawa N; Ishihara S; Takehara Y; Naganawa S; Davenport MS; Terasawa T
Radiology; 2022 Nov; 305(2):341-349. PubMed ID: 35852428
[TBL] [Abstract][Full Text] [Related]
32. Skin Tests for the Exploration of Hypersensitivity Reactions Associated with Iodinated Contrast Media.
Zaiem A; Ben Hammamia S; Ben Salem F; Charfi O; Aouinti I; Kastalli S; Aidli SE; Badri T; Lakhoua G; Mizouni H
Curr Drug Saf; 2022; 17(3):169-175. PubMed ID: 34561992
[TBL] [Abstract][Full Text] [Related]
33. Disinfection byproducts of iopamidol, iohexol, diatrizoate and their distinct acute toxicity on Scenedesmus sp., Daphnia magna and Danio rerio.
Zhou N; Liu H; Yang X; Watson P; Yang F
Chemosphere; 2023 Aug; 333():138885. PubMed ID: 37209847
[TBL] [Abstract][Full Text] [Related]
34. Proposal of a skin tests based approach for the prevention of recurrent hypersensitivity reactions to iodinated contrast media.
Della-Torre E; Berti A; Yacoub MR; Guglielmi B; Tombetti E; Sabbadini MG; Voltolini S; Colombo G
Eur Ann Allergy Clin Immunol; 2015 May; 47(3):77-85. PubMed ID: 25951145
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic approach to hypersensitivity reactions to iodinated contrast media: a single-center experience on 98 patients.
Meucci E; Radice A; Fassio F; Sibilio M; Iorno MLC; Testi S; Severino M; Macchia D
Eur Ann Allergy Clin Immunol; 2020 Sep; 52(5):220-229. PubMed ID: 31920060
[TBL] [Abstract][Full Text] [Related]
36. Nausea and vomiting after exposure to non-ionic contrast media: incidence and risk factors focusing on preparatory fasting.
Kim YS; Yoon SH; Choi YH; Park CM; Lee W; Goo JM
Br J Radiol; 2018 Jul; 91(1087):20180107. PubMed ID: 29694239
[TBL] [Abstract][Full Text] [Related]
37. N-(2,3-dihydroxypropyl) carbamoyl side chain: a potentially significant factor for recurrent iodinated contrast medium-related adverse drug reactions.
Kim PH; Suh CH; Jang EB; Kim S; Park KJ; Park HJ; Kim AY; Do KH; Lee JH; Kim JH; Jung AY; Lee CW
Eur Radiol; 2024 Apr; ():. PubMed ID: 38625610
[TBL] [Abstract][Full Text] [Related]
38. Delayed-type hypersensitivity to a nonionic, radiopaque contrast medium.
Courvoisier S; Bircher AJ
Allergy; 1998 Dec; 53(12):1221-4. PubMed ID: 9930602
[TBL] [Abstract][Full Text] [Related]
39. Extrinsic warming of low-osmolality iodinated contrast media to 37°C reduced the rate of allergic-like reaction.
Zhang B; Liu J; Dong Y; Guo B; Lian Z; Yu H; Luo X; Mo X; Zhang L; Huang W; Ouyang F; Li X; Liang C; Zhang S
Allergy Asthma Proc; 2018 Nov; 39(6):e55-e63. PubMed ID: 30401329
[No Abstract] [Full Text] [Related]
40. Absence of Iodinated Contrast Hypersensitivity and Characterization of Gadolinium Utilization in an Interventional Pain Population.
Kalangara J; Lanier K; Beckworth WJ; Kuruvilla M
Pain Pract; 2021 Feb; 21(2):184-189. PubMed ID: 32898929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
